药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cyclobenzaprine
Cabozantinib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Cabozantinib.
Cyclobenzaprine
Piceatannol
The therapeutic efficacy of Liotrix can be decreased when used in combination with Piceatannol.
Cyclobenzaprine
Axitinib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Axitinib.
Cyclobenzaprine
Pazopanib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Pazopanib.
Cyclobenzaprine
Lestaurtinib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Lestaurtinib.
Cyclobenzaprine
Glesatinib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Glesatinib.
Cyclobenzaprine
Dovitinib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Dovitinib.
Cyclobenzaprine
Motesanib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Motesanib.
Cyclobenzaprine
Tandutinib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Tandutinib.
Cyclobenzaprine
Canertinib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Canertinib.
Cyclobenzaprine
Vandetanib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Vandetanib.
Cyclobenzaprine
Vatalanib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Vatalanib.
Cyclobenzaprine
Cediranib
The therapeutic efficacy of Liotrix can be decreased when used in combination with Cediranib.
Cyclobenzaprine
Radicicol
The therapeutic efficacy of Liotrix can be decreased when used in combination with Radicicol.
Cyclobenzaprine
PD173955
The therapeutic efficacy of Liotrix can be decreased when used in combination with PD173955.
Cyclobenzaprine
Geldanamycin
The therapeutic efficacy of Liotrix can be decreased when used in combination with Geldanamycin.
Cyclobenzaprine
3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone
The therapeutic efficacy of Liotrix can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.
Cyclobenzaprine
Genistein
The therapeutic efficacy of Liotrix can be decreased when used in combination with Genistein.
Cyclobenzaprine
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Liotrix.
Cyclobenzaprine
Mefenorex
The risk or severity of adverse effects can be increased when Mefenorex is combined with Liotrix.